Annual Reports

Quarterly Reports


  • 8-K (Dec 12, 2011)
  • 8-K (Nov 10, 2011)
  • 8-K (Oct 28, 2011)
  • 8-K (Oct 25, 2011)
  • 8-K (Aug 10, 2011)
  • 8-K (Jul 27, 2011)


Adolor 8-K 2005

Documents found in this filing:

  1. 8-K
  2. 8-K
Form 8-K


Washington, D.C. 20549










Date of Report (Date of earliest event reported) November 16, 2005



Adolor Corporation

(Exact name of registrant as specified in its charter)



Delaware   000-30039   31-1429198

(State or other jurisdiction

Of incorporation)

  (Commission File Number)  

(IRS Employer

Identification No.)


700 Pennsylvania Drive, Exton, PA   19341
(Address of principal executive offices)   (Zip Code)


Registrant’s telephone number, including area code: (484) 595-1500


Not Applicable

(Former name or former address, if changed since last report)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 1.01 Entry into a Material Definitive Agreement.


Adolor Corporation, a Delaware corporation (the “Company”), and Corium International, Inc., a Delaware corporation (“Corium”) entered into a Scale Up and Commercial Supply Agreement effective November 16, 2005 (the “Agreement”). Under the terms of the Agreement, Corium will engage in a development program to develop and scale up production of a prescription-only, passive, sterile lidocaine patch (the “Patch”) for human use for pain from closed wounds. The Company will make payments to Corium in exchange for Corium’s performance of its development obligations as outlined in the Agreement. Under the terms of the Agreement, Corium will manufacture clinical supplies of the Patch as ordered by the Company. Under the Agreement, Corium will scale up the production of the Patch. Under the Agreement Corium will be the exclusive supplier of Patches to the Company commencing with the Effective Date and continuing for a period of time agreed by the parties. The Agreement covers ordering terms and provides for commercial supply terms when and if the Patch is approved for commercial sale by the Food and Drug Administration.



Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.



/s/ Martha E. Manning

Name:   Martha E. Manning

Senior Vice President,

General Counsel and Secretary


Dated: November 22, 2005

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki